|
1
|
Llosa NJ, Cruise M, Tam A, Wicks EC,
Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS,
et al: The vigorous immune microenvironment of microsatellite
instable colon cancer is balanced by multiple counter-inhibitory
checkpoints. Cancer Discov. 5:43–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kyu HH, Bachman VF, Alexander LT, Mumford
JE, Afshin A, Estep K, Veerman JL, Delwiche K, Iannarone ML, Moyer
ML, et al: Physical activity and risk of breast cancer, colon
cancer, diabetes, ischemic heart disease, and ischemic stroke
events: Systematic review and dose-response meta-analysis for the
Global Burden of Disease Study 2013. BMJ. 354:i38572016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Sousa e Melo F, Kurtova AV, Harnoss JM,
Kljavin N, Hoeck JD, Hung J, Anderson JE, Storm EE, Modrusan Z,
Koeppen H, et al: A distinct role for Lgr5+ stem cells
in primary and metastatic colon cancer. Nature. 543:676–680. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abdel-Rahman WM, Faris ME and Peltomaki P:
Molecular determinants of colon cancer susceptibility in the East
and West. Curr Mol Med. 17:34–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cayrefourcq L, Mazard T, Joosse S,
Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde
T, Pantel K, et al: Establishment and characterization of a cell
line from human circulating colon cancer cells. Cancer Res.
75:892–901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tie J, Wang Y, Tomasetti C, Li L, Springer
S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, et al:
Circulating tumor DNA analysis detects minimal residual disease and
predicts recurrence in patients with stage II colon cancer. Sci
Transl Med. 8:346ra922016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang S, Gao L, Kathleen K, Fink A, Kalvala
A, Aguila B, Otterson G, Villalonacalero M and Duan W: micoRNA in
FA defective tumor. Cancer Res. 77 Suppl 13:Abst 44422017.
View Article : Google Scholar
|
|
8
|
Nieuwenhuizen L, de Groot PG, Grutters JC
and Biesma DH: A review of pulmonary coagulopathy in acute lung
injury, acute respiratory distress syndrome and pneumonia. Eur J
Haematol. 82:413–425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Yin H, Zhang Y, Feng Y, Yan Z,
Jiang X, Bukhari I, Iqbal F, Cooke HJ and Shi Q: miR-214-mediated
downregulation of RNF8 induces chromosomal instability in ovarian
cancer cells. Cell Cycle. 13:3519–3528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Srivastava A, Goldberger H, Dimtchev A,
Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen
LN, et al: MicroRNA profiling in prostate cancer - the diagnostic
potential of urinary miR-205 and miR-214. PLoS One. 8:e769942013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2 (Delta Delta C(T)) Method. Methods. 25:402 4082001.
View Article : Google Scholar
|
|
12
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 12:e050052015. View Article : Google Scholar
|
|
14
|
Qiang R, Wang F, Shi LY, Liu M, Chen S,
Wan HY, Li YX, Li X, Gao SY and Sun BC: Plexin-B1 is a target of
miR-214 in cervical cancer and promotes the growth and invasion of
HeLa cells. Int J Biochem Cell Biol. 43:632–641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamane K, Jinnin M, Etoh T, Kobayashi Y,
Shimozono N, Fukushima S, Masuguchi S, Maruo K, Inoue Y, Ishihara
T, et al: Down-regulation of miR-124/-214 in cutaneous squamous
cell carcinoma mediates abnormal cell proliferation via the
induction of ERK. J Mol Med (Berl). 91:69–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang
H, Zhou Y, Xiong W, Zhou M, Li X, et al: miR-214 promotes
tumorigenesis by targeting lactotransferrin in nasopharyngeal
carcinoma. Tumour Biol. 34:1793–1800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang SD, Yuan Y, Zhuang CW, Li BL, Gong
DJ, Wang SG, Zeng ZY and Cheng HZ: MicroRNA-98 and microRNA-214
post-transcriptionally regulate enhancer of zeste homolog 2 and
inhibit migration and invasion in human esophageal squamous cell
carcinoma. Mol Cancer. 11:512012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: miR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li B, Han Q, Zhu Y, Yu Y, Wang J and Jiang
X: Down-regulation of miR-214 contributes to intrahepatic
cholangiocarcinoma metastasis by targeting Twist. FEBS J.
279:2393–2398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z
and Jiang J: miR-214 inhibits cell growth in hepatocellular
carcinoma through suppression of β-catenin. Biochem Biophys Res
Commun. 428:525–531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang F, Liu M, Li X and Tang H: miR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia H, Ooi LL and Hui KM: miR-214 targets
β-catenin pathway to suppress invasion, stem-like traits and
recurrence of human hepatocellular carcinoma. PLoS One.
7:e442062012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schwarzenbach H, Milde-Langosch K,
Steinbach B, Müller V and Pantel K: Diagnostic potential of
PTEN-targeting miR-214 in the blood of breast cancer patients.
Breast Cancer Res Treat. 134:933–941. 2012. View Article : Google Scholar : PubMed/NCBI
|
